Vaxcyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Vaxcyte and other ETFs, options, and stocks.About PCVX
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology.
CEOGrant E. Pickering
CEOGrant E. Pickering
Employees414
Employees414
HeadquartersSan Carlos, California
HeadquartersSan Carlos, California
Founded2013
Founded2013
Employees414
Employees414
PCVX Key Statistics
Market cap6.24B
Market cap6.24B
Price-Earnings ratio-9.71
Price-Earnings ratio-9.71
Dividend yield—
Dividend yield—
Average volume1.59M
Average volume1.59M
High today$48.31
High today$48.31
Low today$47.05
Low today$47.05
Open price$47.81
Open price$47.81
Volume629.85K
Volume629.85K
52 Week high$93.77
52 Week high$93.77
52 Week low$27.66
52 Week low$27.66
Stock Snapshot
Vaxcyte(PCVX) stock is priced at $47.65, giving the company a market capitalization of 6.24B. It carries a P/E multiple of -9.71.
On 2025-12-24, Vaxcyte(PCVX) stock traded between a low of $47.05 and a high of $48.31. Shares are currently priced at $47.65, which is +1.3% above the low and -1.4% below the high.
The Vaxcyte(PCVX)'s current trading volume is 629.85K, compared to an average daily volume of 1.59M.
In the last year, Vaxcyte(PCVX) shares hit a 52-week high of $93.77 and a 52-week low of $27.66.
In the last year, Vaxcyte(PCVX) shares hit a 52-week high of $93.77 and a 52-week low of $27.66.
Analyst ratings
90%
of 10 ratingsBuy
90%
Hold
10%
Sell
0%
People also own
Based on the portfolios of people who own PCVX. This list is generated using Robinhood data, and it’s not a recommendation.